CTHRC1 and pancreatic neoplasm: Similarly, we also examined the effect of adding the LIF inhibitor to CAFs‐CM overexpressing CTHRC1 on the proliferation and migration of pancreatic cancer cells using CCK‐8, colony formation, and Transwell migration assays.